Geneventiv said the FDA had "positive" feedback in a meeting on developing GENV-HEM, the company's gene therapy for ...
Data and Digital Preservation colleagues report back from the ninth edition of the No Time To Wait conference.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback